Table 4 Approaches towards facilitating DHA integration into healthcare
Question: Thinking about your previous experience with DHAs: What further improvements would you like to see in DHAs? (n = 546) | Overall approval |
|---|---|
(Further) optimization of the usability of DHAs, especially towards more simple, intuitive, and target group-compliant use to prevent issues such as measurement and user error | 59% |
Structured further training programs for doctors on using DHAs in healthcare, especially primary care, such as by planning a sufficient range of CME-certified training courses | 53% |
Inclusion of appropriate remuneration for medical services and additional expenses provided in connection with DHAs in the German doctors’ fee schedule | 52% |
A reliable manufacturer-agnostic information platform focused on DHAs, ideally under state administration – suggestions include the National Health Portal) | 52% |
More gamification elements for a more playful, interactive approach to patient management | 49% |
(Further) improvement on information security and data privacy by creating more binding and uniform privacy standards for manufacturers | 48% |
Clearly exclude liability risks for doctors if, for example, bugs in a DHA should lead to treatment error – liability and responsibility should not lie with care providers or patients | 45% |
DHAs should be specifically designed to avoid exacerbating health anxiety, such as by preventing misinterpretation by patients or excessive fixation on individual health data items | 42% |
Increased advice and support for patients by statutory health insurance organizations specifically referring to DHAs | 41% |
Make more convincing arguments for the importance and benefits of (comprehensive) digitalization in healthcare towards increasing their willingness to integrate this into their own patient healthcare services | 34% |
Removal of temporary DHA approval in the fast-track procedure, thus tightening the evaluation procedure | 33% |
Technical aspects of integrating DHAs into everyday routine at medical practices such as by providing a cost-neutral and functional connection to software used at the practice | 23% |
Insured people from all statutory health insurance organizations should receive bonuses or bonus programs for using certain DHAs regularly and forwarding their data to the statutory health insurance organization | 7% |